Discontinued — last reported Q3 '23
Arch Capital Group Equity Method Investments increased by 3.1% to $6.65B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $6.34B to $6.65B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 25.8% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.54B | $2.74B | $3.08B | $3.33B | $3.50B | $3.57B | $3.77B | $3.90B | $4.07B | $4.25B | $4.57B | $4.84B | $4.98B | $5.24B | $5.98B | $6.34B | $6.57B | $6.23B | $6.45B | $6.65B |
| QoQ Change | — | +8.0% | +12.3% | +8.1% | +5.1% | +2.0% | +5.8% | +3.2% | +4.5% | +4.4% | +7.4% | +6.0% | +2.9% | +5.2% | +14.0% | +6.0% | +3.6% | -5.1% | +3.5% | +3.1% |
| YoY Change | — | — | — | — | +37.7% | +30.1% | +22.6% | +17.2% | +16.5% | +19.2% | +21.0% | +24.3% | +22.3% | +23.4% | +31.0% | +30.9% | +31.8% | +18.8% | +7.9% | +4.9% |